Competitive Landscape: Key Market Leaders and New Entrants in the Peripheral Artery Disease Market

The peripheral artery disease (PAD) market is positioned for significant expansion over the coming years, driven by technological progress and heightened awareness. As healthcare providers adopt innovative treatment options and early diagnostic tools, this sector is set to see notable advancements. Below is an in-depth look at the market size, key players, emerging trends, and segmentation details shaping the future of the PAD landscape.

Strong Growth Expected in the Peripheral Artery Disease Market by 2030
The peripheral artery disease market is forecasted to grow considerably, reaching a valuation of $6.69 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 7.8% during the forecast period. The surge in market value is primarily driven by innovations in minimally invasive peripheral interventions, increased use of drug-eluting balloons and stents, expansion of hospitals and specialty vascular clinics, and greater patient awareness leading to earlier detection. Furthermore, combination therapies that blend lifestyle changes with pharmacological treatments are gaining traction. Key trends anticipated to influence this market include the adoption of artificial intelligence (AI) for early PAD diagnosis and risk assessment, a rise in cloud-based patient monitoring systems, growing emphasis on personalized PAD therapies guided by genomics, integration of Internet of Things (IoT) devices for tracking after interventions, and the implementation of smart manufacturing in producing PAD devices.

Download a free report of the peripheral artery disease market report:
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Notable Participants Driving the Peripheral Artery Disease Market
Several prominent companies dominate the peripheral artery disease sector, including Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton dic*kinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., and Avinger Inc.

A significant development occurred in April 2023 when Abbott Laboratories, a US-based medical device manufacturer, acquired Cardiovascular Systems Inc. Although the financial details were not disclosed, this acquisition enriches Abbott's portfolio in peripheral and coronary artery disease by incorporating the innovative atherectomy system developed by Cardiovascular Systems Inc., a company specializing in PAD products.

View the full peripheral artery disease market report:
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Innovations Reshaping the Peripheral Artery Disease Market
Key players in the PAD market are concentrating on creating pioneering solutions such as dissolvable drug-eluting scaffold systems that respond to the increasing demand for safer, longer-lasting, and less invasive treatments for below-the-knee arterial blockages. These bioresorbable scaffold technologies help restore blood flow and then dissolve gradually, offering advantages over permanent metal stents. In April 2024, Abbott Laboratories introduced the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a groundbreaking dissolvable stent therapy designed specifically for below-the-knee PAD. This system delivers everolimus, a drug that prevents vessel narrowing, while its fully absorbable structure dissolves over time, eliminating risks tied to permanent metal implants. It provides clinicians with an advanced alternative to traditional angioplasty or permanent stents, particularly benefiting patients with complex lesions or critical limb ischemia. By combining drug delivery with temporary structural support, this system aims to improve vessel healing, reduce complications, and broaden treatment possibilities in challenging PAD cases.

Segments Defining the Peripheral Artery Disease Market
The peripheral artery disease market is segmented into several categories as follows:

By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories.

By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytic Agents, Anti-Inflammatory Agents.

By Route of Administration: Oral, Parenteral, Other Routes of Administration.

By End Users: Hospitals, Specialty Clinics, Other End Users.

Further subcategories include:
- Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons.
- Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents.
- Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters.
- Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters.
- Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices.
- Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices.
- Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices.

This comprehensive segmentation enables a nuanced understanding of the market dynamics and facilitates targeted strategies by manufacturers and healthcare providers alike.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.